Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Triple Negative Breast Neoplasms
×
Anthracyclines
×
Clear all
Filters
3
NCT02622074
2020-09-10
KEYNOTE 173
Merck Sharp & Dohme LLC
Phase 1
Completed
60 enrolled
26 charts